Correlation Between Immutep and Day One
Can any of the company-specific risk be diversified away by investing in both Immutep and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immutep Ltd ADR and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Immutep and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and Day One.
Diversification Opportunities for Immutep and Day One
Very good diversification
The 3 months correlation between Immutep and Day is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Immutep i.e., Immutep and Day One go up and down completely randomly.
Pair Corralation between Immutep and Day One
Given the investment horizon of 90 days Immutep Ltd ADR is expected to generate 1.31 times more return on investment than Day One. However, Immutep is 1.31 times more volatile than Day One Biopharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 214.00 in Immutep Ltd ADR on October 22, 2024 and sell it today you would lose (21.00) from holding Immutep Ltd ADR or give up 9.81% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 99.19% |
Values | Daily Returns |
Immutep Ltd ADR vs. Day One Biopharmaceuticals
Performance |
Timeline |
Immutep Ltd ADR |
Day One Biopharmaceu |
Immutep and Day One Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immutep and Day One
The main advantage of trading using opposite Immutep and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.Immutep vs. Ocean Biomedical | Immutep vs. Elevation Oncology | Immutep vs. Zura Bio Limited | Immutep vs. Cns Pharmaceuticals |
Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets |